Sorrento Therapeutics Inc (SRNE)
0.015
0.00 (0.00%)
USD |
OTCM |
Apr 23, 09:55
Sorrento Therapeutics Debt to Equity Ratio: -0.6928 for June 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2023 | -0.6928 |
| March 31, 2023 | -0.566 |
| December 31, 2022 | -1.904 |
| September 30, 2022 | 0.5363 |
| June 30, 2022 | 0.8088 |
| March 31, 2022 | 0.6755 |
| December 31, 2021 | 1.811 |
| September 30, 2021 | 0.844 |
| June 30, 2021 | 0.6039 |
| March 31, 2021 | 0.4393 |
| December 31, 2020 | 0.6992 |
| September 30, 2020 | 0.8177 |
| June 30, 2020 | 1.210 |
| March 31, 2020 | 1.975 |
| December 31, 2019 | 2.995 |
| September 30, 2019 | 5.670 |
| June 30, 2019 | 3.063 |
| March 31, 2019 | 1.806 |
| December 31, 2018 | 1.114 |
| September 30, 2018 | 0.7842 |
| June 30, 2018 | 0.0696 |
| March 31, 2018 | 0.0302 |
| December 31, 2017 | 0.0261 |
| September 30, 2017 | 0.2059 |
| June 30, 2017 | 0.2872 |
| Date | Value |
|---|---|
| March 31, 2017 | 0.4514 |
| December 31, 2016 | 0.5912 |
| September 30, 2016 | 0.0709 |
| June 30, 2016 | 0.0483 |
| March 31, 2016 | 0.085 |
| December 31, 2015 | 0.0636 |
| September 30, 2015 | 0.0709 |
| June 30, 2015 | 0.1258 |
| March 31, 2015 | 0.1219 |
| December 31, 2014 | 0.1117 |
| September 30, 2014 | 0.1705 |
| June 30, 2014 | 0.1544 |
| March 31, 2014 | 0.2029 |
| December 31, 2013 | 0.0719 |
| September 30, 2013 | 0.155 |
| June 30, 2013 | 0.1434 |
| March 31, 2013 | 0.0848 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.904
Minimum
Dec 2022
5.670
Maximum
Sep 2019
1.117
Average
0.8088
Median
Jun 2022
Debt to Equity Ratio Benchmarks
| Scilex Holding Co | -0.7255 |
| AIM ImmunoTech Inc | 0.00 |
| Perspective Therapeutics Inc | 0.0229 |
| Protalix BioTherapeutics Inc | 0.6033 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 456.69M |
| Total Liabilities (Quarterly) | 654.65M |
| Shareholders Equity (Quarterly) | -205.11M |
| Current Ratio | 0.5024 |
| Net Debt Paydown Yield | 1.11% |